Ftse Mib
35.124,59
0,00%
DAX
20.271,33
0,67%
S&P 500
5.842,91
0,11%
NASDAQ
19.044,39
-0,23%
Bitcoin
97.235,91
0,76%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Renovaro Inc (RENB) Renovaro Inc (RENB) Notizie

Renovaro Inc

RENB
0,8382
-0,0619 (-6,88%)
15 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/1/202522:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/1/202522:09EDGAR2Form 8-K - Current report
07/1/202523:26EDGAR2Form 8-K - Current report
07/1/202515:15GLOBERenovaro Appoints Nathen Fuentes as Chief Financial Officer
06/1/202523:19EDGAR2Form 8-K - Current report
06/1/202515:15GLOBERenovaro to Acquire Predictive Oncology in All-Stock..
30/12/202415:00GLOBERenovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube..
23/12/202415:00GLOBERenovaroCube Receives Approval of Lumina Project by the..
20/12/202421:40GLOBERenovaro Regains Compliance with NASDAQ Listing Requirement
20/12/202415:00GLOBERenovaro Enters into a Strategic Collaboration with Nebul to..
21/11/202422:19EDGAR2Form 8-K - Current report
14/11/202422:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202422:32EDGAR2Form 8-K - Current report
07/11/202418:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202423:45EDGAR2Form SC 13D/A - General Statement of Acquisition of..
06/11/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202414:31GLOBERenovaro Issues Shareholder Letter and Provides Corporate..
30/10/202421:30EDGAR2Form S-3 - Registration statement under Securities Act of..
29/10/202421:21EDGAR2Form 8-K/A - Current report: [Amend]
29/10/202419:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202422:10EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
24/10/202414:57EDGAR2Form SC 13D/A - General Statement of Acquisition of..
24/10/202414:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202415:15GLOBERenovaroCube Presents Novel Insights on Non-Invasive Cancer..
16/10/202415:28GLOBERenovaro Announces Strategic Restructuring and Leadership..
16/10/202414:34EDGAR2Form 8-K - Current report
10/10/202422:33EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/10/202422:02EDGAR2Form NT 10-K - Notification of inability to timely file Form..
19/9/202415:00GLOBEPersonalAIze and Cube Forge Groundbreaking Partnership to..
17/9/202423:15EDGAR2Form 8-K - Current report
17/9/202415:00GLOBEIndependent Expert Assessment Validates RenovaroCube’s..
13/9/202415:00GLOBERenovaroCube to Present Cutting-Edge Cancer Diagnostics..
11/9/202416:30EDGAR2Form 8-K - Current report
11/9/202415:15GLOBERenovaroCube Announces Strategic Offering of Up to 20%..
27/8/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202413:53EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
19/8/202422:05EDGAR2Form 8-K - Current report
13/8/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/7/202414:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/7/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/6/202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202415:06GLOBERenovaro, Inc. Announces $10 million in Equity Committed
11/6/202417:29EDGAR2Form 144 - Report of proposed sale of securities
06/6/202421:52EDGAR2Form 144 - Report of proposed sale of securities
31/5/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:33EDGAR2Form 8-K - Current report
24/5/202416:19EDGAR2Form 8-K - Current report
24/5/202415:20GLOBERenovaro Inc. and Amsterdam UMC Cancer Center Poised to..
Apertura: 0,935 Min: 0,79 Max: 0,935
Chiusura: 0,9001

La tua Cronologia

NASDAQ
RENB
Renovaro
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network